Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Translational Medicine|October 26, 2023
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimabDomenico Mallardo, Rachel Woodford, Alexander M Menzies, et al.Cancers|July 14, 2023
Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter StudyDirk Tomsitz, Theresa Ruf, Markus Heppt, et al.The Journal of Clinical Investigation|May 1, 2025
Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T-cells in uveal melanoma patientsRamon Staeger, Aizhan Tastanova, Adhideb Ghosh, et al.The Lancet. Haematology|February 6, 2026
Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trialRudolf Stadler, Pietro Quaglino, F J Sherida H Woei-A-Jin, et al.Nature Medicine|July 13, 2026
An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trialMatteo S Carlino, Ellen Kapiteijn, Sophie Piperno-Neumann, et al.Journal for Immunotherapy of Cancer|July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanomaPrachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.Journal of Hematology & Oncology|July 10, 2026
Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumorsIgnacio Melero, María de Miguel, Elena Garralda Cabanas, et al.European Journal of Cancer (Oxford, England : 1990)|March 16, 2025
Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence studyMichael Weichenthal, Eva Ellebaek, Joanna Mangana, et al.Nature|December 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIgnacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.Pageof 6